Investment
Features
FeesSafety
Academy
More
Pluang+

ALUULA reports 58% revenue growth YTD with new Vancouver facility to boost production capacity.

Company Fundamentals
22 Sep 2026
Newsfile Corp
View Source
Bullish
ALUULA reports 58% revenue growth YTD with new Vancouver facility to boost production capacity.

ALUULA Composites Inc. reported a 58% increase in year-to-date revenue to CAD 7.86 million, driven by strong growth in its Commercial Industrial and Performance Outdoor segments. Despite a lower Q3 gross margin of 32% due to investments in larger-width materials and production scaling, the company is expanding its manufacturing capacity with a new Vancouver facility expected to be fully operational by October 2026. ALUULA also secured funding for R&D projects under Canada's Industrial and Technological Benefits Policy, supporting maritime defense applications. The company expects continued investment through 2027 to build scalable production and improve margins once the new facility stabilizes.

ALUULA's third quarter 2026 results provide context for basic materials investors. For readers following this sector, here is Pluang's market snapshot as of Sep 23, 2026 04:11 WIB: Among 38 priced Basic Materials-sector US stocks, 28 rose and 10 fell. Notably, WPM traded at USD 154.10 with a 1-day change of +4.36% and a typical hold time of 64 days, while EXK was at USD 10.55, up +4.15% with a shorter hold time of 24 days. SCCO stood at USD 206.00, rising +4.01% but with a contrasting Pluang order activity skewed 74% Sell / 26% Buy.

More News

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital rates Tenet Healthcare 'Market Perform' with 24% EPS growth forecast

BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...

Analyst Insights
Neutral
2 hours ago
Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Stocks JAGX, GRML, and VKTX soar on FDA approvals, biotech data, and mineral interest.

Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...

Market News
Bullish
2 hours ago
Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

Market downturn hits top stocks: New Fortress Energy falls nearly 25%, quantum and tech stocks also slide.

The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...

Market News
Bearish
2 hours ago
Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Capri Holdings rated Hold amid takeover uncertainty but expects growth from new products and marketing.

Jefferies maintains a Hold rating on Capri Holdings due to uncertainty over a potential takeover. Despite a flat global luxury market, Capri's management expects growth in the second half of 2026, driven by new product launches, increased marketing, ...

Analyst Insights
Neutral
2 hours ago
NEAR Protocol's cross-chain system surpasses $30B volume with record daily trades and 78% token surge

NEAR Protocol's cross-chain system surpasses $30B volume with record daily trades and 78% token surge

NEAR Protocol's cross-chain execution layer, NEAR Intents, has exceeded $30 billion in cumulative trading volume, reaching about $31.4 billion. On September 18, it recorded a daily volume over $300 million, contributing to a weekly volume between $84...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App